Published in Cochrane Database Syst Rev on July 08, 2009
Prevalence of BRCA1 and BRCA2 mutations in women with breast carcinoma In Situ and referred for genetic testing. Cancer Prev Res (Phila) (2010) 0.79
Accelerated partial breast irradiation compared with whole breast radiation therapy: a breast cancer cohort study measuring change in radiation side-effects severity and quality of life. Breast Cancer Res Treat (2017) 0.75
Practical methods for incorporating summary time-to-event data into meta-analysis. Trials (2007) 14.51
Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One (2008) 13.32
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev (2015) 11.05
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial. Lancet (2007) 9.24
Taking healthcare interventions from trial to practice. BMJ (2010) 3.27
An international registry of systematic-review protocols. Lancet (2010) 3.12
Bumps and bridges on the road to responsible sharing of clinical trial data. Clin Trials (2014) 2.87
The nuts and bolts of PROSPERO: an international prospective register of systematic reviews. Syst Rev (2012) 2.86
The quality of registration of clinical trials. PLoS One (2011) 2.42
Duration of chemotherapy for metastatic breast cancer: a systematic review and meta-analysis of randomized clinical trials. J Clin Oncol (2011) 2.10
Clinical practice guidelines for communicating prognosis and end-of-life issues with adults in the advanced stages of a life-limiting illness, and their caregivers. Med J Aust (2007) 1.99
Incidence of metastatic breast cancer in an Australian population-based cohort of women with non-metastatic breast cancer at diagnosis. Med J Aust (2012) 1.95
A systematic review of prognostic/end-of-life communication with adults in the advanced stages of a life-limiting illness: patient/caregiver preferences for the content, style, and timing of information. J Pain Symptom Manage (2007) 1.92
PROSPERO at one year: an evaluation of its utility. Syst Rev (2013) 1.83
What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile? Lancet Oncol (2005) 1.77
Establishing a minimum dataset for prospective registration of systematic reviews: an international consultation. PLoS One (2011) 1.66
Guidance for evidence-informed policies about health systems: assessing how much confidence to place in the research evidence. PLoS Med (2012) 1.62
Truth-telling in discussing prognosis in advanced life-limiting illnesses: a systematic review. Palliat Med (2007) 1.60
Single agent versus combination chemotherapy for metastatic breast cancer. Cochrane Database Syst Rev (2009) 1.46
Sustaining hope when communicating with terminally ill patients and their families: a systematic review. Psychooncology (2008) 1.42
Beyond chemotherapy--demystifying the new 'targeted' cancer treatments. Aust Fam Physician (2008) 1.39
Research protocols: waiving confidentiality for the greater good. BMJ (2006) 1.24
SafeTalk, a multicomponent, motivational interviewing-based, safer sex counseling program for people living with HIV/AIDS: a qualitative assessment of patients' views. AIDS Patient Care STDS (2010) 1.24
Prospective registration of clinical trials. Aust J Physiother (2006) 1.18
Discrepant perceptions about end-of-life communication: a systematic review. J Pain Symptom Manage (2007) 1.08
Registering clinical trials in India: a scientific and ethical imperative. Natl Med J India (2008) 1.05
Project power: Adapting an evidence-based HIV/STI prevention intervention for incarcerated women. AIDS Educ Prev (2013) 1.01
Effectiveness of service linkages in primary mental health care: a narrative review part 1. BMC Health Serv Res (2011) 0.99
Combination versus sequential single agent chemotherapy for metastatic breast cancer. Cochrane Database Syst Rev (2013) 0.99
Building effective service linkages in primary mental health care: a narrative review part 2. BMC Health Serv Res (2011) 0.96
Metastatic breast cancer. Aust Fam Physician (2006) 0.95
HIV-infected prison inmates: depression and implications for release back to communities. AIDS Behav (2008) 0.92
Post-operative radiotherapy for ductal carcinoma in situ of the breast. Cochrane Database Syst Rev (2009) 0.91
Post-operative radiotherapy for ductal carcinoma in situ of the breast--a systematic review of the randomised trials. Breast (2009) 0.91
Addition of drug/s to a chemotherapy regimen for metastatic breast cancer. Cochrane Database Syst Rev (2010) 0.89
Taxane-containing regimens for metastatic breast cancer. Cochrane Database Syst Rev (2015) 0.88
Preventive evidence into practice (PEP) study: implementation of guidelines to prevent primary vascular disease in general practice protocol for a cluster randomised controlled trial. Implement Sci (2013) 0.88
Post-operative radiotherapy for ductal carcinoma in situ of the breast. Cochrane Database Syst Rev (2013) 0.88
Context of risk for HIV and sexually transmitted infections among incarcerated women in the south: individual, interpersonal, and societal factors. Women Health (2014) 0.88
Prevalence and predictors of concurrent sexual partnerships in a predominantly African American population in Jackson, Mississippi. AIDS Behav (2014) 0.88
Antibiotics for ureaplasma in the vagina in pregnancy. Cochrane Database Syst Rev (2011) 0.86
Impact of baseline and nadir neutrophil index in non-small cell lung cancer and ovarian cancer patients: Assessment of chemotherapy for resolution of unfavourable neutrophilia. J Transl Med (2013) 0.85
Hormone replacement therapy and breast cancer risk in California. Breast J (2005) 0.84
Pharmacokinetic research in children: an analysis of registered records of clinical trials. BMJ Open (2011) 0.83
Triple-negative breast cancer: making the most of a misnomer. Asia Pac J Clin Oncol (2012) 0.83
HRT and breast cancer: impact on population risk and incidence. Eur J Cancer (2005) 0.82
Use of non-anthracycline regimens in early stage breast cancer in Australia. Asia Pac J Clin Oncol (2010) 0.80
Selective mastectomy in the management of locally advanced breast cancer. Int J Radiat Oncol Biol Phys (2007) 0.79
The background review for the USPSTF recommendation on screening for breast cancer. Ann Intern Med (2010) 0.79
The ClinicalTrials.gov results database. N Engl J Med (2011) 0.79
Making systematic reviews global. Cochrane Database Syst Rev (2011) 0.79
Response to: Practical methods for incorporating summary time-to-event data into meta. Authors' reply. Trials (2013) 0.79
Management of early breast cancer--the current approach. Aust Fam Physician (2005) 0.78
Information on blinding in registered records of clinical trials. Trials (2012) 0.78
Post-operative radiotherapy for ductal carcinoma in situ of the breast. Cochrane Database Syst Rev (2009) 0.77
The Australian Clinical Trial Registry. Med J Aust (2005) 0.77
Physical activity and fitness in women with metastatic breast cancer. J Cancer Surviv (2014) 0.76
In postmenopausal women with breast cancer treated with aromatase inhibitors, denosumab reduced fractures. Ann Intern Med (2015) 0.75
Treating metastatic breast cancer: the evidence for targeted therapy. Cochrane Database Syst Rev (2014) 0.75
Hormone replacement therapy and breast cancer: estimate of risk. BMJ (2005) 0.75
Platinum-containing regimens for metastatic breast cancer. Cochrane Database Syst Rev (2017) 0.75
Systemic treatment of HER2+ metastatic breast cancer: clinical conundrums and future perspectives. Asia Pac J Clin Oncol (2014) 0.75
Building chronic disease management capacity in General Practice: The South Australian GP Plus Practice Nurse Initiative. Collegian (2015) 0.75
Antidepressants and tamoxifen: interaction concerns. Australas Psychiatry (2013) 0.75